Showing results (61-70 of 120) with videos related to
Sort By:
Pageof 12
The Journal of Biological Chemistry|May 7, 2013
Vascular Ehlers-Danlos syndrome mutations in type III collagen differently stall the triple helical foldingKazunori Mizuno, Sergei Boudko, Jürgen Engel, et al.Proceedings of the National Academy of Sciences of the United States of America|July 5, 2012
Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1Szymon W Manka, Federico Carafoli, Robert Visse, et al.Molecular Biosystems|August 10, 2016
Panels of chemically-modified heparin polysaccharides and natural heparan sulfate saccharides both exhibit differences in binding to Slit and Robo, as well as variation between protein binding and cellular activityYassir A Ahmed, Edwin A Yates, Diana J Moss, et al.Nature Chemical Biology|August 16, 2016
Structural basis of laminin binding to the LARGE glycans on dystroglycanDavid C Briggs, Takako Yoshida-Moriguchi, Tianqing Zheng, et al.Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Biologically-active laminin-111 fragment that modulates the epithelial-to-mesenchymal transition in embryonic stem cellsChristine-Maria Horejs, Andrea Serio, Alan Purvis, et al.Biophysical Journal|June 17, 2010
Kinetic hysteresis in collagen foldingKazunori Mizuno, Sergei P Boudko, Jürgen Engel, et al.Journal of Molecular Biology|May 29, 2004
Design and crystal structure of bacteriophage T4 mini-fibritin NCCFSergei P Boudko, Sergei V Strelkov, Jürgen Engel, et al.Current Drug Delivery|October 16, 2008
Modification of the in vitro release profile of Cetrorelix by complexation with biophilic partnersThomas Rattei, Jürgen Engel, Wolfgang Naumann, et al.Journal of Neurochemistry|September 2, 2005
A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survivalAlexandra A Anderson, Claire E Kendal, Mitla Garcia-Maya, et al.Neuroendocrinology|June 13, 2009
Luteinizing hormone-releasing hormone receptor-targeted chemotherapy using AN-152Günter Emons, Herbert Sindermann, Jürgen Engel, et al.Pageof 12